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Immunity and Inflammation and the BHF Centre of Excellence in Vascular Science and 
Medicine. He is the Senior Honours Immunology degree programme coordinator in Glasgow 
and serves on the Executive Committee of the International Union of Basic and Clinical 
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authored over 60 scientific papers in peer-reviewed journals including Immunity, Circulation, 
PNAS, and Blood. He is an elected fellow of the Royal Society of Biology, the British 
Pharmacological Society and the European Society of Cardiology. 
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Peer review is a fundamental process used to identify the strengths and weaknesses of a 
research article and is at the core of Cardiovascular Research’s activities.1 It ensures that 
misinterpreted or misleading data are not published and enhances the general quality of 
published papers. I have to admit, that although some of the comments received on my own 
manuscripts have not always been welcome, the peer-review process has improved the 
overall quality of my scientific outputs. As a general principle, getting critical feedback can 
help us appreciate our work with fresh eyes, and may lead to new analysis, experiments and 
occasionally to interesting and unexplored research avenues. Therefore, the peer review 
process is key to improve the quality of scientific research. 
The peer review process has been used for centuries since its formal implementation by the 
Royal Society of London in the 18th century; however, it is far from being perfect. One of the 
major problems is the lack of standardization in the critical evaluation of the scientific data. 
As a consequence, peer review is highly subjective and therefore not scientifically objective. 
Improving the standard and consistency of the peer process is of the upmost importance. 
Scientists rarely receive formal training on how to approach peer review, making the 
introduction of standardized training for all researchers a necessity to achieve consistent and 
appropriate reviewing. The number of published articles is rising each year,2,3 increasing the 
pressure on editors to identify suitable and available reviewers to meet the demand. The 
number of scientists in the life sciences far exceeds the demand for peer review,4 however, 
the problem is not to find available reviewers, but to find expert and qualified reviewers able 
to deliver consistent, critical evaluation of manuscripts in a short time frame. In addition, 
recent cases of fraudulent review, where authors impersonated fake reviewers in order to 
have their work accepted for publication,5 highlighted the importance of establishing a 
system where reviewers are traceable, properly trained and evaluated over time. 
Publons (https://publons.com/home/) was created to tackle most of these issues. Founded by 
Andrew Preston and Daniel Johnston in New Zealand in 2012, the platform has grown 
steadily over the years and was recently acquired by Clarivate Analytics 
(https://clarivate.com/), the global leader which owns the Web of Science citation database 
focusing on scientific and academic research analytics. Together, these companies now own 
large data sets of scientific authorship, citation patterns and peer-review across thousands of 
journals. 
The main goal of Publons is to turn peer review into a rewarding activity. Researchers can 
post profiles of their peer review history and editorial contributions and with this demonstrate 
in a tangible manner their contributions to the field. The service is completely free and offers 
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the possibility to compare your reviewing behaviour with others around the world, together 
with winning awards for peer reviewing such as the ‘Sentinels of Science and Research’. 
Ultimately, the platform should spur academics to conduct better peer reviews, and more of 
them. Of note, peer review per se is not sufficient to accelerate your career, but it is 
encouraging to see that at world-class universities like Harvard peer review and editorial 
activities must be reported in annual evaluations. 
In the past five years Publons has accumulated a user-base of over 290,000 scientists, with 
1.6 million reviews listed for over 25,000 journals and Publons is set to expand under the 
new partnership with Clarivate. On one hand, the predictable expansion of Publons members 
may pave the way for the creation of a global database of reviewers, which may improve the 
integrity, quality and timeliness of academic publishing. On the other hand, Clarivate may 
now develop tools that assess the quality of researchers and Institutions, based also on the 
peer review data collated by Publons and not only on the Web of Science’s citation records. 
On this note, it’s interesting to see that in the current Publons Review World Rankings two of 
the top UK institutions, University College London and University of Cambridge, are in the 
top ten list. 
Training is an important aspect of Publons. Through the Publons Academy, researchers can 
receive practical peer review training, with sessions spanning from academic publishing to 
evaluating data, results and ethics. Publons already partners with the world's publishers and 
leading organisations (Springer Nature, Oxford University Press, Wolters Klumer, Wiley and 
The Royal Society among the others) and integrates with the main peer review submission 
systems (e.g. ScholarOne, Editorial Manager, Open Journal System, etc.). Therefore, in the 
foreseeable future, we may see Publons as an integrated digital platform where reviewers are 
fully trained, identified via their ORCID digital identifier (https://orcid.org/), assessed on the 
quality and performance of peer review and fully rewarded for their contribution. These tools 
would greatly help editors to identify suitable reviewers, would favour a more transparent 
and fair distribution of the peer review workload and ultimately improve the quality of 
science communication. 
An improved system may also increase speed of dissemination and stimulate new models of 
review. Open review, for example, has been adopted by journals like PeerJ, F1000Research, 
and the Frontiers publishing group; however, it is still considered a controversial subject in 
my opinion, simply because of the lack of a standardized review process. Another interesting 
development could be represented by preprint servers such as bioRxiv 
(https://www.biorxiv.org/), which may become the medium for quick data dissemination 
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allowing a lengthier and in depth post-publication peer review process. 
In summary, the partnership Clarivate and Publons may assist in modernising the peer review 
system, providing highly trained reviewers rewarded for their service to the scientific 
community. 
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